Show simple item record
Author | dc.contributor.author | Durán, Javier | |
Author | dc.contributor.author | Estrada Hormazábal, Manuel | |
Admission date | dc.date.accessioned | 2018-08-13T18:58:18Z | |
Available date | dc.date.available | 2018-08-13T18:58:18Z | |
Publication date | dc.date.issued | 2018 | |
Cita de ítem | dc.identifier.citation | Frontiers in Pharmacology April 2018 | Volume 9 | Article 381 | es_ES |
Identifier | dc.identifier.other | 10.3389/fphar.2018.00381 | |
Identifier | dc.identifier.uri | https://repositorio.uchile.cl/handle/2250/150942 | |
Patrocinador | dc.description.sponsorship | Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)
1151118 | es_ES |
Lenguage | dc.language.iso | en | es_ES |
Publisher | dc.publisher | Frontiers Media | es_ES |
Type of license | dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | * |
Link to License | dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | * |
Source | dc.source | Frontiers in Pharmacology | es_ES |
Keywords | dc.subject | Bimagrumab | es_ES |
Keywords | dc.subject | ActRIIA/B receptors | es_ES |
Keywords | dc.subject | Skeletal muscle | es_ES |
Keywords | dc.subject | Anabolic steroids | es_ES |
Keywords | dc.subject | Myostatin/activin | es_ES |
Título | dc.title | Commentary: Blockade of activin type II receptors with a dual anti-actRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy | es_ES |
Document type | dc.type | Artículo de revista | |
dcterms.accessRights | dcterms.accessRights | Acceso abierto | |
Cataloguer | uchile.catalogador | rgf | es_ES |
Indexation | uchile.index | Artículo de publicación ISI | es_ES |
Files in this item
- Name:
- Commentary-Blockade-of-activin ...
- Size:
- 198.8Kb
- Format:
- PDF
This item appears in the following Collection(s)
Show simple item record
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile